FDA-approved medications for Cushing's syndrome include osilodrostat (Isturisa), levoketoconazole (Recorlev), pasireotide (Signifor), and mifepristone (Korlym)the latter specifically indicated for hyperglycemia secondary to Cushing's syndrome
PT-141 acts on the brains melanocortin receptors to improve sexual desire, increase sexual arousal, and support visual sexual stimulation responses, which can be especially beneficial for premenopausal women and men with hypoactive sexual desire disorder PDE5 inhibitors enhance erectile response by increasing blood flow, nitric oxide release, and penile muscle relaxation, leading to a penile erection sufficient for sexual intercourse This approach may improve sexual performance and erectile response in patients with mixed psychological aspects and vascular contributors, including those with mild cardiovascular disease or blood flow limitations
58,156,162 Future Perspectives GLP-1 RAs Currently Under Development Based on previous findings, dosages that enable longer durations and less frequent administrations have been investigated
Central antihypertensive mechanism of clonidine